These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 27117099)
21. Myocardial PKC beta2 and the sensitivity of Na/K-ATPase to marinobufagenin are reduced by cicletanine in Dahl hypertension. Fedorova OV; Talan MI; Agalakova NI; Droy-Lefaix MT; Lakatta EG; Bagrov AY Hypertension; 2003 Mar; 41(3):505-11. PubMed ID: 12623951 [TBL] [Abstract][Full Text] [Related]
22. Systemic hypertension: the roles of salt, vascular Na+/K+ ATPase and the endogenous glycosides, ouabain and marinobufagenin. Hauck C; Frishman WH Cardiol Rev; 2012; 20(3):130-8. PubMed ID: 22183064 [TBL] [Abstract][Full Text] [Related]
23. Interaction between cardiotonic steroids and Na,K-ATPase. Effects of pH and ouabain-induced changes in enzyme conformation. Cornelius F; Mahmmoud YA Biochemistry; 2009 Oct; 48(42):10056-65. PubMed ID: 19778013 [TBL] [Abstract][Full Text] [Related]
24. Abnormalities of sodium pump function in hypertension and the role of endogenous cardiotonic steroids. Doris PA Cell Mol Biol (Noisy-le-grand); 2001 Mar; 47(2):391-401. PubMed ID: 11357900 [TBL] [Abstract][Full Text] [Related]
25. Endogenous digitalis-like ligands and Na/K-ATPase inhibition in experimental diabetes mellitus. Bagrov YY; Manusova NB; Egorova IA; Fedorova OV; Bagrov AY Front Biosci; 2005 Sep; 10():2257-62. PubMed ID: 15970492 [TBL] [Abstract][Full Text] [Related]
26. Effects of cardiac glycosides on sodium pump expression and function in LLC-PK1 and MDCK cells. Liu J; Periyasamy SM; Gunning W; Fedorova OV; Bagrov AY; Malhotra D; Xie Z; Shapiro JI Kidney Int; 2002 Dec; 62(6):2118-25. PubMed ID: 12427136 [TBL] [Abstract][Full Text] [Related]
27. Endogenous digitalis-like factors: their possible pathophysiological implications with particular regard to the perinatal period. Biver P; Clerico A; Paci A; Balzan S; Boldrini A; Cipolloni C Child Nephrol Urol; 1990; 10(3):164-80. PubMed ID: 1962738 [TBL] [Abstract][Full Text] [Related]
28. Marinobufagenin, an endogenous ligand of alpha-1 sodium pump, is a marker of congestive heart failure severity. Fridman AI; Matveev SA; Agalakova NI; Fedorova OV; Lakatta EG; Bagrov AY J Hypertens; 2002 Jun; 20(6):1189-94. PubMed ID: 12023690 [TBL] [Abstract][Full Text] [Related]
29. Endogenous cardiotonic steroids and cardiovascular disease, where to next? Pavlovic D Cell Calcium; 2020 Mar; 86():102156. PubMed ID: 31896530 [TBL] [Abstract][Full Text] [Related]
30. [Na+, K(+)-ATPase, endogenous cardiotonic steroids and their transducing role]. Tsymbaliuk OV; Kosterin SO Ukr Biokhim Zh (1999); 2012; 84(1):5-17. PubMed ID: 22679753 [TBL] [Abstract][Full Text] [Related]
31. Marinobufagenin, an endogenous inhibitor of alpha-1 Na/K-ATPase, is a novel factor in pathogenesis of diabetes mellitus. Bagrov YY; Manusova NB; Egorova IA; Frolova EV; Fedorova OV; Bagrov AY Dokl Biol Sci; 2005; 404():333-7. PubMed ID: 16405108 [No Abstract] [Full Text] [Related]
32. The Cardiotonic Steroid Marinobufagenin Is a Predictor of Increased Left Ventricular Mass in Obesity: The African-PREDICT Study. Strauss-Kruger M; Kruger R; Smith W; Gafane-Matemane LF; Mokwatsi G; Wei W; Fedorova OV; Schutte AE Nutrients; 2020 Oct; 12(10):. PubMed ID: 33081045 [TBL] [Abstract][Full Text] [Related]
33. [Involvement of ouabain (digitalis-like factor) in the pathogenesis of hypertension and hypertensive target-organ damage]. Goto A; Yamada K Nihon Rinsho; 2004 Mar; 62 Suppl 3():169-73. PubMed ID: 15171364 [No Abstract] [Full Text] [Related]
34. Simultaneous measurement of marinobufagenin, ouabain, and hypertension-associated protein in various disease states. Gonick HC; Ding Y; Vaziri ND; Bagrov AY; Fedorova OV Clin Exp Hypertens; 1998; 20(5-6):617-27. PubMed ID: 9682918 [TBL] [Abstract][Full Text] [Related]
35. Synthesis of an Endogenous Steroidal Na Pump Inhibitor Marinobufagenin, Implicated in Human Cardiovascular Diseases, Is Initiated by CYP27A1 via Bile Acid Pathway. Fedorova OV; Zernetkina VI; Shilova VY; Grigorova YN; Juhasz O; Wei W; Marshall CA; Lakatta EG; Bagrov AY Circ Cardiovasc Genet; 2015 Oct; 8(5):736-45. PubMed ID: 26374826 [TBL] [Abstract][Full Text] [Related]